Skip to content
AP

Arch Pharmalabs

524729 BSE
Price unavailable
View as Markdown
MCP

No trades in 1Y

Key Insights

No strengths listed

Weaknesses

5
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -10.3% over past five years.
  • Company has a low return on equity of -18.5% over last 3 years.
  • Company has high debtors of 911 days.
  • Working capital days have increased from 674 days to 1,485 days

Growth Rate

Annual windows: The latest annual results are more than two years old, so no annual growth is shown.

Trailing twelve months: No quarterly results are reported.

Not shown: Quarterly Results. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.

Profit & Loss

₹ Cr
524729 profit and loss, annual, ₹ crore
Particulars Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
Sales
539
981
1,162
1,425
1,771
2,265
569
Expenses
437
805
897
1,077
1,321
2,016
626
Operating Profit
102
176
264
348
450
248
−57
OPM %
19%
18%
23%
24%
25%
11%
−10%
Other Income
4
0
7
6
22
13
2
Interest
38
82
143
167
242
307
332
Depreciation
18
33
52
66
84
96
104
PBT
50
61
76
122
146
−141
−491
Tax %
28%
30%
27%
29%
27%
10%
−13%
Net Profit
35
43
56
87
106
−154
−428
Div. Payout %
0%
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
524729 balance sheet, annual, ₹ crore
Particulars Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
Equity Capital
21
21
21
25
25
28
28
Reserves
325
362
443
650
750
751
1,307
Borrowings
420
954
1,248
1,382
1,615
2,386
3,145
Other Liabilities
103
257
322
441
678
847
472
Total Liabilities
869
1,594
2,035
2,498
3,067
4,012
4,952
Fixed Assets
301
529
645
768
848
921
1,795
CWIP
32
135
97
30
63
34
31
Investments
19
0
0
0
0
0
0
Other Assets
518
930
1,293
1,699
2,156
3,057
3,125
Total Assets
869
1,594
2,035
2,498
3,067
4,012
4,952

Cash Flow

₹ Cr
524729 cash flow, annual, ₹ crore
Particulars Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
Operating
—
−183
−17
187
239
−447
−511
Investing
—
−339
−132
−262
−187
−150
−2
Financing
—
466
169
77
−25
630
426
Net Cash Flow
—
−55
20
1
27
33
−86
Free Cash Flow
—
−540
−142
−68
72
−609
−514
CFO/OP
—
−100
−2
59
61
−177
892

Ratios

524729 financial ratios, annual
Particulars Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
Debtor Days
111
132
168
153
152
189
911
Inventory Days
180
204
217
213
211
215
672
Days Payable
80
53
111
144
179
148
279
Cash Conversion Cycle
212
283
275
222
184
256
1,304
Working Capital Days
229
257
307
282
239
299
1,485
ROCE %
—
14%
14%
15%
17%
6%
−4%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Arch Pharmalabs insights

29 extracted metrics across FY08–FY26.

Shareholding Pattern

Not shown: Shareholding Pattern. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.

Documents

Frequently Asked Questions about Arch Pharmalabs

Where is Arch Pharmalabs Ltd (524729) listed?
Arch Pharmalabs Ltd trades under code 524729 on the BSE.

Company Information

Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524729.md for Arch Pharmalabs Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More